Scinai Immunotherapeutics (SCNI) Current Assets (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Current Assets for 2 consecutive years, with $2.1 million as the latest value for Q4 2025.
- Quarterly Current Assets fell 14.09% to $2.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, down 14.09% year-over-year, with the annual reading at $2.1 million for FY2025, 14.09% down from the prior year.
- Current Assets hit $2.1 million in Q4 2025 for Scinai Immunotherapeutics, down from $2.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $2.4 million in Q4 2024 to a low of $2.1 million in Q4 2025.